Board of Advisors
Samuel Z. Goldhaber, M.D.
Professor of Cardiovascular Medicine, Peter Bent Brigham Hospital, Harvard Medical School, in Boston, Massachusetts, is an internationally recognized expert in vascular diseases.
Director, Anticoagulation Service, and Director, Venous Thromboembolism Research Group at Brigham and Women's Hospital. Dr. Goldhaber's clinical interests include pulmonary embolism, general clinical cardiology, coronary artery disease, peripheral vascular disease, atrial fibrillation, anticoagulation treatment, chronic venous insufficiency and thrombolstic therapy.
Timothy Morris, M.D.
Associate Professor of Medicine and Director, Pulmonary Clinical Program, Department of Pulmonary and Critical Care Medicine, University of California San Diego Medical Center in San Diego, California. Dr. Morriss is a recognized expert in the diagnosis of thromboembolic disease. Dr. Morris' clinical interests include general pulmonary medicine, acute pulmonary thromboembolic disease and critical care.
Erkki Ruoslahti, M.D., Ph.D.
Distinguished Professor and Director of the Vascular Mapping Center at the Burnham Institute for Medical Research at the University of California Santa Barbara. Dr. Ruoslahti is an internationally recognized scientist in the areas of vascular targeting peptide technology, vascular biology, cell adhesion, and tumor biology. Dr. Ruoslahti served as President and CEO of the Burnham Institute from 1989 to 2001, has published more than 400 scientific papers, and is the inventor of more than 150 patents. His inventions form the basis of two clinically used drugs as well as several that are under development. He has co-founded several biotech companies and has served as a director or advisory board member of these and other companies. His honors include: elected membership to the U.S. National Academy of Sciences, Institute of Medicine, American Academy of Arts and Sciences, and the European Molecular Biology Organization. He is the recipient of the G.H.A. Clowes Award, Robert J. and Claire Pasarow Foundation Award, Jacobaeus International Prize, The Jubilee Award given by the British Biomedical Society. He was a Nobel Fellow at the Karolinska Institute in Stockholm in 1995, and is an Honorary Doctor of Medicine from the University of Lund, as well as a Knight of the Order of the White Rose of Finland. Dr. Ruoslahti is the recipient of the 2005 Japan Prize in Cell Biology.
For more information on Dr. Ruoslahti:
http://www.burnham.org/FacultyAndResearch/faculty/erkki_ruoslahti_bio.asp
David Warburton, M.D., F.R.C.P.
Professor of Pediatrics, University of Southern California School of Medicine, Director, Developmental Biology Program, Children's Hospital Los Angeles Research Institute in Los Angeles, California, is a recognized expert in developmental biology.Dr. Warburton's research interests include molecular embryology, stem cell biology, lung development and lung morphogenesis.
Family of Companies
